期刊文献+

前列通方治疗前列腺增生症52例疗效观察 被引量:1

Therapeutic efficacy of Qianlietong prescription in treatment of prostatic hyperplasia:a report of 52 cases
原文传递
导出
摘要 目的:观察前列通方治疗前列腺增生症的临床疗效。方法:将本病104例随机分为治疗组和对照组各52例,治疗组采用前列通方治疗,对照组采用癃闭舒胶囊治疗。两组均以治疗4周为1个疗程,共治疗3个疗程后观察比较两组疗效。结果:总有效率治疗组为80.8%,对照组为55.8%,两组比较,差异有统计学意义(P<0.05)。结论:前列通方治疗前列腺增生症疗效满意。 Objective : To observe the therapeutic efficacy of Qianlietong prescription in the treatment of prostatic hyperplasia. Methods :A total of 104 patients with prostatic hyperplasia were randomly divided into treatment group (n = 52) and control group (n = 52). The treatment group received Qianlietong prescription, while the control group received Longbishu capsules. The treatment outcomes of the two groups were compared after 3 courses of treatment (4 weeks each). Results:The treatment group had a significantly higher overall response rate than the control group (80. 8% vs 55.8% ,P 〈0.05). Conclusion : Qianlietong prescription has satisfying therapeutic efficacy in the treat- ment of prostatic hyperplasia.
出处 《湖南中医杂志》 2013年第6期16-17,共2页 Hunan Journal of Traditional Chinese Medicine
基金 湖南省科技计划项目(编号:2010SK3148)
关键词 前列腺增生症 中医药疗法 前列通方 prostatic hyperplasia traditional Chinese medicine treatment Qianlietong prescription
  • 相关文献

共引文献112

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部